Nuclear targeting of stanniocalcin to mammary gland alveolar cells during pregnancy and lactation
Authors:
- Christopher R. McCuddenCMChristopher R. McCudden
- J. Ryan J. GillespieJGJ. Ryan J. Gillespie
- Kathi A. JamesKJKathi A. James
- Edward R. HirviEHEdward R. Hirvi
- Deenaz ZaidiDZDeenaz Zaidi
- Graham F. WagnerGWGraham F. Wagner
Open Access
- 1 October 2005
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 289 (4) , E634-E642
Abstract
In most mammalian tissues, the stanniocalcin-1 gene (STC-1) produces a 50-kDa polypeptide hormone known as STC50. Within the ovaries, however, the STC-1 gene generates three higher-molecular-mass variants known as big STC. Big STC is targeted locally to corpus luteal cells to block progesterone release. During pregnancy and lactation, however, ovarian big STC production increases markedly, and the hormone is released into the serum. During lactation, this increase in hormone production is dependent on a suckling stimulus, suggesting that ovarian big STC may have regulatory effects on the lactating mammary gland. In this report, we have addressed this possibility. Our results revealed that virgin mammary tissue contained large numbers of membrane- and mitochondrial-associated STC receptors. However, as pregnancy progressed into lactation, there was a decline in receptor densities on both organelles and a corresponding rise in nuclear receptor density, most of which were on milk-producing, alveolar cells. This was accompanied by nuclear sequestration of the ligand. Sequestered STC resolved as one ∼135-kDa band in the native state and therefore had the appearance of a big STC variant. However, chemical reduction collapsed this one band into six closely spaced, lower-molecular-mass species (28–41 kDa). Mammary gland STC production also underwent a dramatic shift during pregnancy and lactation. High levels of STC gene expression were observed in mammary tissue from virgin and pregnant rats. However, gene expression then fell to nearly undetectable levels during lactation, coinciding with the rise in nuclear targeting. These findings have thus shown that the mammary glands are indeed targeted by STC, even in the virgin state. They have further shown that there are marked changes in this targeting pathway during pregnancy and lactation, accompanied by a switch in ligand source (endogenous to exogenous). They also represent the first example of nuclear targeting by STC.Keywords
This publication has 42 references indexed in Scilit:
- Evidence for stanniocalcin binding activity in mammalian blood and glomerular filtrateKidney International, 2005
- Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomasMolecular and Cellular Endocrinology, 2004
- Characterization of Mammalian Stanniocalcin ReceptorsJournal of Biological Chemistry, 2002
- Overexpression of Human Stanniocalcin Affects Growth and Reproduction in Transgenic MiceEndocrinology, 2002
- Possible roles for stanniocalcin during early skeletal patterning and joint formation in the mouseJournal of Endocrinology, 2001
- Isolation of Nuclei and Nuclear Membranes From Animal TissuesCurrent Protocols in Cell Biology, 2001
- Predominant Intracellular Localization of the Type I Transforming Growth Factor-β Receptor and Increased Nuclear Accumulation after Growth ArrestExperimental Cell Research, 2000
- Angiotensin II-Induced Nuclear Targeting of the Angiotensin Type 1 (AT1) Receptor in Brain NeuronsEndocrinology, 1998
- A novel human cDNA highly homologous to the fish hormone stanniocalcinMolecular and Cellular Endocrinology, 1995
- Purification, characterization, and bioassay of teleocalcin, a glycoprotein from salmon corpuscles of StanniusGeneral and Comparative Endocrinology, 1986